Cragun, J., Xiong, Y., Boren, T. P., Indermaur, M. D., Sayer, R., Humphrey, M. M., … Lancaster, J. M. (2009). Genomic predictors of ovarian cancer response to salvage therapy. GYNECOLOGIC ONCOLOGY, 112(2), S133–S133.

Cragun, J., Y. Xiong, T. P. Boren, M. D. Indermaur, R. Sayer, M. M. Humphrey, H. M. Cottrill, et al. “Genomic predictors of ovarian cancer response to salvage therapy.” GYNECOLOGIC ONCOLOGY 112, no. 2 (February 1, 2009): S133–S133.

Cragun J, Xiong Y, Boren TP, Indermaur MD, Sayer R, Humphrey MM, et al. Genomic predictors of ovarian cancer response to salvage therapy. GYNECOLOGIC ONCOLOGY. 2009 Feb 1;112(2):S133–S133.

Cragun, J., et al. “Genomic predictors of ovarian cancer response to salvage therapy.” GYNECOLOGIC ONCOLOGY, vol. 112, no. 2, ACADEMIC PRESS INC ELSEVIER SCIENCE, Feb. 2009, pp. S133–S133.

Cragun J, Xiong Y, Boren TP, Indermaur MD, Sayer R, Humphrey MM, Cottrill HM, Kamath S, Hakam A, Apte SM, Wenham RM, Berchuck A, Lancaster JM. Genomic predictors of ovarian cancer response to salvage therapy. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2009 Feb 1;112(2):S133–S133.